Intragastric Balloon as a First Step Before Metabolic Bariatric Surgery in Patients with BMI ≥ 50 kg/m2: are the Results After Balloon Related to Global Outcomes After Surgery? - Takeaways - MDSpire

Intragastric Balloon as a First Step Before Metabolic Bariatric Surgery in Patients with BMI ≥ 50 kg/m2: are the Results After Balloon Related to Global Outcomes After Surgery?

  • By

  • André Costa Pinho

  • Alexandra Luís Manco

  • Marco Silva

  • Hugo Santos Sousa

  • Fernando Resende

  • John Preto

  • Eduardo Lima da Costa

  • July 23, 2024

  • 0 min

Share

  • 1

    Obesity is a chronic disease linked to serious health risks, including hypertension, diabetes, and cancer, particularly in patients with BMI ≥ 50 kg/m2.

  • 2

    Intragastric balloon (IGB) serves as a neoadjuvant therapy for metabolic bariatric surgery (MBS), helping to reduce risks in high-BMI patients.

  • 3

    IGB placement involves a multidisciplinary evaluation to assess patient risks and contraindications before proceeding with the procedure.

  • 4

    The study aims to evaluate outcomes of IGB before MBS and its influence on weight loss and comorbidity resolution post-surgery.

  • 5

    Complications from IGB can include nausea and respiratory issues, necessitating careful monitoring and follow-up after balloon removal.

Original Source(s)

Intragastric Balloon as a First Step Before Metabolic Bariatric Surgery in Patients with BMI ≥ 50 kg/m2: are the Results After Balloon Related to Global Outcomes After Surgery?

  • by André Costa Pinho, Alexandra Luís Manco, Marco Silva, Hugo Santos Sousa, Fernando Resende, John Preto, Eduardo Lima da Costa

  • July 23, 2024

Related Content

The Heresy of Hypoabsorptive Bariatric Surgery: A Critical Reappraisal of Long-Term Outcomes and Clinical Trade-Offs

Editorial: Impact of dietary factors on human gut microbiota and gastrointestinal endocrinology

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population